Connect with us

Life Sciences

Call for abstracts and registration are open for ISSCR 2023 annual meeting 14-17 June 2023

Abstracts and registration are open for the ISSCR 2023 Annual Meeting, the most comprehensive gathering of scientists in stem cell research and regenerative…

Published

on

This article was originally published by BioEngineering

Abstracts and registration are open for the ISSCR 2023 Annual Meeting, the most comprehensive gathering of scientists in stem cell research and regenerative medicine in the world. Taking place 14-17 June 2023 in Boston, USA, a global powerhouse for biomedical innovation, this hallmark event, co-sponsored by BlueRock Therapeutics, offers attendees opportunities for scientific exchange and relationship building for an unparalleled experience that showcases the year’s most compelling stem cell research and clinical breakthroughs.

ISSCR 2023

Credit: International Society for Stem Cell Research

Abstracts and registration are open for the ISSCR 2023 Annual Meeting, the most comprehensive gathering of scientists in stem cell research and regenerative medicine in the world. Taking place 14-17 June 2023 in Boston, USA, a global powerhouse for biomedical innovation, this hallmark event, co-sponsored by BlueRock Therapeutics, offers attendees opportunities for scientific exchange and relationship building for an unparalleled experience that showcases the year’s most compelling stem cell research and clinical breakthroughs.

“The society is thrilled to be back in Boston, one of the finest destinations for biotechnology research in the world,” Haifan Lin, PhD, ISSCR President said. “We have had a year of exciting research in the field, including significant clinical advances that are driving us toward new innovations that have the potential to alleviate intractable diseases and disorders. The ISSCR 2023 Annual Meeting will highlight the best and most compelling stem cell science worldwide.”

Submit an abstract by 8 February 2023 to be considered for an oral presentation and to qualify for Travel and Merit Awards. Late-breaking abstracts will be open from 22 February to 22 March 2023 and will be considered for poster presentations. Take advantage of early registration through 8 March 2023. Virtual options are available.

ISSCR 2023 will feature unpublished research that explores new technologies and clinical applications of stem cell research. Each day is focused around one or more of five, defined scientific themes that guide attendees to key sessions aligned with research interests. Attendees will be able to take part in dedicated poster sessions on site and peruse the virtual Poster Theater at any time, with options for in person and virtual attendees to interact and to schedule meetings with all of the scientific program presenters. All attendees will have access to sessions on demand for 30 days after the meeting concludes.

New this year is an opportunity for ISSCR members to design a scientific session – to take a deep dive on a scientific topic not already explored in the annual meeting program. Science Spotlight sessions are a chance for early-career scientists and students to bring together presenters from across the field into a session that presents several new areas of research related to a particular topic.

Learn about ISSCR 2023 Plenaries and Concurrent Track sessions themes and invited speakers. Members of the press are encouraged to apply for media credentials for complimentary registration.

About the International Society for Stem Cell Research (www.isscr.org
With nearly 4,600+ members from 80 countries worldwide, the International Society for Stem Cell Research is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health. Additional information about stem cell science is available at A Closer Look at Stem Cells, an initiative of the Society to inform the public about stem cell research and its potential to improve human health.

###

 



stem cells

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending